The Effects of Astilbin on Cognitive Impairments in a Transgenic Mouse Model of Alzheimer’s Disease
Authors:
- 19 July 2016
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 37 (4) , 695-706
Abstract
Bioflavonoids are being utilised as neuroprotectants in the treatment of various neurological disorders, including Alzheimer’s disease (AD). Astilbin, a bioflavanoid, has been reported to have potent neuroprotective effects, but its preventive effects on amyloid-β (Aβ)-induced, Alzheimer’s disease-related, cognitive impairment, and the underlying mechanisms of these effects have not been well characterised. Five-month-old APPswe/PS1dE9 transgenic mice were randomly assigned to a vehicle group and two astilbin (either 20 or 40 mg/kg per day, intraperitoneally) groups. After 8 weeks of treatment, we observed beneficial effects of astilbin (40 mg/kg per day), including lessening learning and memory deficits and reducing plaque burden and Aβ levels. Furthermore, the expressions of both the cAMP responsive element-binding protein (CREB) and brain-derived neurotrophic factor (BDNF) were significantly increased and the disturbance of AKT/GSK-3β signalling pathway was markedly ameliorated in the hippocampus of astilbin-treated (40 mg/kg per day) group. Our data suggest that astilbin might be a potential therapeutic agent against AD.Keywords
Funding Information
- National Natural Science Foundation of China (U1304806)
- the China Scholarship Council (No.201408410296)
- the Young Backbone Teachers Assistance Scheme of Henan Province Colleges and Universities
- the Scientific Research Fund of Henan University of Science and Technology (No.09001664)
This publication has 66 references indexed in Scilit:
- Age-dependent Accumulation of Soluble Amyloid β (Aβ) Oligomers Reverses the Neuroprotective Effect of Soluble Amyloid Precursor Protein-α (sAPPα) by Modulating Phosphatidylinositol 3-Kinase (PI3K)/Akt-GSK-3β Pathway in Alzheimer Mouse ModelJournal of Biological Chemistry, 2011
- Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouseMolecular Neurodegeneration, 2011
- The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementiaBrain, 2010
- Postsynaptic BDNF‐TrkB signaling in synapse maturation, plasticity, and diseaseDevelopmental Neurobiology, 2010
- Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's diseaseJournal of Neuroinflammation, 2010
- Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's diseaseNature Medicine, 2009
- The neuroprotective potential of flavonoids: a multiplicity of effectsGenes & Nutrition, 2008
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008
- The GSK3 hypothesis of Alzheimer’s diseaseJournal of Neurochemistry, 2007
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976